PHARMACOKINETICS AND ABSOLUTE BIOAVAILAB
β
Lisa Jo Benincosa; Patricia R. Audet; Dave Lundberg; NΓ©vine Zariffa; Diane K. Jo
π
Article
π
1996
π
John Wiley and Sons
π
English
β 509 KB
The objective of the current investigation was to describe the pharmacokinetics and absolute oral bioavailability of epristeride. Twelve healthy male subjects (mean (SD) age, 27 (6.2) years) received a single oral dose of 5mg and an intravenous infusion of 4.5 mg over 30 min in a crossover fashion.